Cet anticorps anti-BCL2L2 Monoclonal Souris (Clone CPTC-BCL2L2-2) (ABIN6654581) détecte spécifiquement BCL2L2 dans IHC (p).
L’anticorps est réactif avec des échantillons de Humain.
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Bcl2L2 antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)
Restrictions
For Research Use only
Buffer
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store the Bcl2L2 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Antigène
BCL2L2
(BCL2-Like 2 (BCL2L2))
Autre désignation
Bcl2L2 / Bcl-W
Sujet
Bcl2L2, also called BCLW, promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.